nodes	percent_of_prediction	percent_of_DWPC	metapath
Nedocromil—HSP90AA1—larynx—head and neck cancer	0.0585	0.187	CbGeAlD
Nedocromil—HSP90AA1—exocrine gland—head and neck cancer	0.0242	0.0774	CbGeAlD
Nedocromil—HSP90AA1—hair follicle—head and neck cancer	0.0231	0.0737	CbGeAlD
Nedocromil—FPR1—lymphoid tissue—head and neck cancer	0.0224	0.0715	CbGeAlD
Nedocromil—HSP90AA1—mouth—head and neck cancer	0.0181	0.0579	CbGeAlD
Nedocromil—FPR1—head—head and neck cancer	0.018	0.0576	CbGeAlD
Nedocromil—PTGDR—head—head and neck cancer	0.017	0.0544	CbGeAlD
Nedocromil—HSP90AA1—neck—head and neck cancer	0.0155	0.0495	CbGeAlD
Nedocromil—HSP90AA1—parotid gland—head and neck cancer	0.0126	0.0403	CbGeAlD
Nedocromil—HSP90AA1—saliva-secreting gland—head and neck cancer	0.0121	0.0386	CbGeAlD
Nedocromil—PTGDR—lymph node—head and neck cancer	0.0119	0.0381	CbGeAlD
Nedocromil—HSP90AA1—connective tissue—head and neck cancer	0.0111	0.0355	CbGeAlD
Nedocromil—HSP90AA1—epithelium—head and neck cancer	0.0105	0.0337	CbGeAlD
Nedocromil—CYSLTR1—lymphoid tissue—head and neck cancer	0.00936	0.0299	CbGeAlD
Nedocromil—HSP90AA1—trachea—head and neck cancer	0.00933	0.0298	CbGeAlD
Nedocromil—HSP90AA1—lymphoid tissue—head and neck cancer	0.00812	0.0259	CbGeAlD
Nedocromil—CYSLTR1—head—head and neck cancer	0.00754	0.0241	CbGeAlD
Nedocromil—HSP90AA1—thyroid gland—head and neck cancer	0.00738	0.0235	CbGeAlD
Nedocromil—HSP90AA1—head—head and neck cancer	0.00654	0.0209	CbGeAlD
Nedocromil—CYSLTR1—lymph node—head and neck cancer	0.00528	0.0169	CbGeAlD
Nedocromil—HSP90AA1—lymph node—head and neck cancer	0.00458	0.0146	CbGeAlD
Nedocromil—Photophobia—Vinblastine—head and neck cancer	0.00307	0.0445	CcSEcCtD
Nedocromil—Stinging—Fluorouracil—head and neck cancer	0.00265	0.0384	CcSEcCtD
Nedocromil—Rash erythematous—Docetaxel—head and neck cancer	0.00203	0.0293	CcSEcCtD
Nedocromil—Photophobia—Fluorouracil—head and neck cancer	0.00202	0.0292	CcSEcCtD
Nedocromil—Otitis media—Docetaxel—head and neck cancer	0.00199	0.0288	CcSEcCtD
Nedocromil—Pharyngitis—Vinblastine—head and neck cancer	0.00163	0.0236	CcSEcCtD
Nedocromil—PTGDR—Signaling Pathways—GRP—head and neck cancer	0.00134	0.00217	CbGpPWpGaD
Nedocromil—Eosinophilia—Fluorouracil—head and neck cancer	0.00133	0.0193	CcSEcCtD
Nedocromil—HSP90AA1—Cellular responses to stress—SOD2—head and neck cancer	0.00133	0.00215	CbGpPWpGaD
Nedocromil—CYSLTR2—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK3—head and neck cancer	0.00132	0.00213	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—STAT6—head and neck cancer	0.0013	0.0021	CbGpPWpGaD
Nedocromil—HSP90AA1—Corticotropin-releasing hormone—MAPK3—head and neck cancer	0.00129	0.00209	CbGpPWpGaD
Nedocromil—HSP90AA1—TNF alpha Signaling Pathway—MAPK3—head and neck cancer	0.00129	0.00209	CbGpPWpGaD
Nedocromil—Leukopenia—Vinblastine—head and neck cancer	0.00128	0.0185	CcSEcCtD
Nedocromil—CYSLTR2—Signaling Pathways—KISS1—head and neck cancer	0.00128	0.00207	CbGpPWpGaD
Nedocromil—HSP90AA1—Cellular responses to stress—GPX1—head and neck cancer	0.00127	0.00205	CbGpPWpGaD
Nedocromil—Upper respiratory tract infection—Fluorouracil—head and neck cancer	0.00125	0.0181	CcSEcCtD
Nedocromil—CYSLTR2—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK1—head and neck cancer	0.00125	0.00203	CbGpPWpGaD
Nedocromil—CYSLTR2—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—head and neck cancer	0.00125	0.00203	CbGpPWpGaD
Nedocromil—HSP90AA1—Cell Cycle—RAD51—head and neck cancer	0.00125	0.00202	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling by GPCR—GRP—head and neck cancer	0.00123	0.002	CbGpPWpGaD
Nedocromil—HSP90AA1—TNF alpha Signaling Pathway—MAPK1—head and neck cancer	0.00123	0.00199	CbGpPWpGaD
Nedocromil—HSP90AA1—Corticotropin-releasing hormone—MAPK1—head and neck cancer	0.00123	0.00199	CbGpPWpGaD
Nedocromil—CYSLTR2—G alpha (q) signalling events—PIK3CA—head and neck cancer	0.00122	0.00197	CbGpPWpGaD
Nedocromil—HSP90AA1—VEGFA-VEGFR2 Pathway—VEGFA—head and neck cancer	0.00121	0.00196	CbGpPWpGaD
Nedocromil—Pneumonia—Fluorouracil—head and neck cancer	0.00121	0.0175	CcSEcCtD
Nedocromil—FPR1—Signaling Pathways—YAP1—head and neck cancer	0.00119	0.00193	CbGpPWpGaD
Nedocromil—HSP90AA1—Fcgamma receptor (FCGR) dependent phagocytosis—PIK3CA—head and neck cancer	0.00118	0.00191	CbGpPWpGaD
Nedocromil—HSP90AA1—Integrins in angiogenesis—AKT1—head and neck cancer	0.00118	0.00191	CbGpPWpGaD
Nedocromil—Conjunctivitis—Fluorouracil—head and neck cancer	0.00117	0.0169	CcSEcCtD
Nedocromil—Leukopenia—Hydroxyurea—head and neck cancer	0.00117	0.0169	CcSEcCtD
Nedocromil—HSP90AA1—Validated targets of C-MYC transcriptional activation—TP53—head and neck cancer	0.00117	0.00189	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—YAP1—head and neck cancer	0.00115	0.00186	CbGpPWpGaD
Nedocromil—HSP90AA1—VEGFA-VEGFR2 Pathway—MAPK3—head and neck cancer	0.00114	0.00185	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling by VEGF—VEGFA—head and neck cancer	0.00114	0.00185	CbGpPWpGaD
Nedocromil—HSP90AA1—Glucocorticoid receptor regulatory network—TP53—head and neck cancer	0.00113	0.00183	CbGpPWpGaD
Nedocromil—Sinusitis—Fluorouracil—head and neck cancer	0.00113	0.0163	CcSEcCtD
Nedocromil—HSP90AA1—Signaling events mediated by VEGFR1 and VEGFR2—AKT1—head and neck cancer	0.00111	0.0018	CbGpPWpGaD
Nedocromil—HSP90AA1—Regulation of Telomerase—AKT1—head and neck cancer	0.00111	0.0018	CbGpPWpGaD
Nedocromil—HSP90AA1—VEGFA-VEGFR2 Pathway—MAPK1—head and neck cancer	0.00109	0.00176	CbGpPWpGaD
Nedocromil—CYSLTR2—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—head and neck cancer	0.00109	0.00176	CbGpPWpGaD
Nedocromil—Rhinitis—Fluorouracil—head and neck cancer	0.00108	0.0157	CcSEcCtD
Nedocromil—HSP90AA1—Signaling by VEGF—MAPK3—head and neck cancer	0.00108	0.00175	CbGpPWpGaD
Nedocromil—Pharyngitis—Fluorouracil—head and neck cancer	0.00107	0.0155	CcSEcCtD
Nedocromil—CYSLTR2—Signaling Pathways—GRP—head and neck cancer	0.00105	0.0017	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling by VEGF—MAPK1—head and neck cancer	0.00103	0.00166	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—STAT6—head and neck cancer	0.00102	0.00165	CbGpPWpGaD
Nedocromil—CYSLTR2—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—head and neck cancer	0.00101	0.00163	CbGpPWpGaD
Nedocromil—Pain—Vinblastine—head and neck cancer	0.000999	0.0145	CcSEcCtD
Nedocromil—HSP90AA1—TNF alpha Signaling Pathway—HRAS—head and neck cancer	0.000987	0.0016	CbGpPWpGaD
Nedocromil—HSP90AA1—EPH-Ephrin signaling—HRAS—head and neck cancer	0.00097	0.00157	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling by ERBB2—PTEN—head and neck cancer	0.000957	0.00155	CbGpPWpGaD
Nedocromil—HSP90AA1—Glucocorticoid receptor regulatory network—AKT1—head and neck cancer	0.000955	0.00155	CbGpPWpGaD
Nedocromil—Gastrointestinal pain—Vinblastine—head and neck cancer	0.000955	0.0138	CcSEcCtD
Nedocromil—Dyspnoea—Hydroxyurea—head and neck cancer	0.00095	0.0138	CcSEcCtD
Nedocromil—HSP90AA1—VEGFA-VEGFR2 Pathway—PIK3CA—head and neck cancer	0.000945	0.00153	CbGpPWpGaD
Nedocromil—Dyspepsia—Hydroxyurea—head and neck cancer	0.000938	0.0136	CcSEcCtD
Nedocromil—Abdominal pain—Vinblastine—head and neck cancer	0.000923	0.0134	CcSEcCtD
Nedocromil—Gastrointestinal disorder—Hydroxyurea—head and neck cancer	0.000919	0.0133	CcSEcCtD
Nedocromil—Fatigue—Hydroxyurea—head and neck cancer	0.000918	0.0133	CcSEcCtD
Nedocromil—CYSLTR1—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK3—head and neck cancer	0.000913	0.00148	CbGpPWpGaD
Nedocromil—Pain—Hydroxyurea—head and neck cancer	0.000911	0.0132	CcSEcCtD
Nedocromil—CYSLTR2—Signaling Pathways—YAP1—head and neck cancer	0.000903	0.00146	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling by VEGF—PIK3CA—head and neck cancer	0.000892	0.00144	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—KISS1—head and neck cancer	0.000884	0.00143	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling by EGFR in Cancer—PTEN—head and neck cancer	0.00088	0.00142	CbGpPWpGaD
Nedocromil—HSP90AA1—VEGFA-VEGFR2 Pathway—HRAS—head and neck cancer	0.000875	0.00142	CbGpPWpGaD
Nedocromil—Pneumonia—Docetaxel—head and neck cancer	0.000873	0.0126	CcSEcCtD
Nedocromil—HSP90AA1—TNF alpha Signaling Pathway—AKT1—head and neck cancer	0.000871	0.00141	CbGpPWpGaD
Nedocromil—HSP90AA1—Corticotropin-releasing hormone—AKT1—head and neck cancer	0.000871	0.00141	CbGpPWpGaD
Nedocromil—CYSLTR1—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK1—head and neck cancer	0.000868	0.00141	CbGpPWpGaD
Nedocromil—CYSLTR1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—head and neck cancer	0.000868	0.00141	CbGpPWpGaD
Nedocromil—Hypersensitivity—Vinblastine—head and neck cancer	0.00086	0.0125	CcSEcCtD
Nedocromil—Conjunctivitis—Docetaxel—head and neck cancer	0.000843	0.0122	CcSEcCtD
Nedocromil—CYSLTR1—G alpha (q) signalling events—PIK3CA—head and neck cancer	0.000843	0.00136	CbGpPWpGaD
Nedocromil—Body temperature increased—Hydroxyurea—head and neck cancer	0.000842	0.0122	CcSEcCtD
Nedocromil—Leukopenia—Fluorouracil—head and neck cancer	0.000841	0.0122	CcSEcCtD
Nedocromil—HSP90AA1—Cell Cycle, Mitotic—TYMS—head and neck cancer	0.00084	0.00136	CbGpPWpGaD
Nedocromil—Asthenia—Vinblastine—head and neck cancer	0.000838	0.0121	CcSEcCtD
Nedocromil—HSP90AA1—Signaling by VEGF—HRAS—head and neck cancer	0.000826	0.00134	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling by ERBB2—MAPK3—head and neck cancer	0.000818	0.00132	CbGpPWpGaD
Nedocromil—Chest pain—Fluorouracil—head and neck cancer	0.0008	0.0116	CcSEcCtD
Nedocromil—Diarrhoea—Vinblastine—head and neck cancer	0.000799	0.0116	CcSEcCtD
Nedocromil—HSP90AA1—Immune System—STAT6—head and neck cancer	0.000785	0.00127	CbGpPWpGaD
Nedocromil—Hypersensitivity—Hydroxyurea—head and neck cancer	0.000785	0.0114	CcSEcCtD
Nedocromil—Rhinitis—Docetaxel—head and neck cancer	0.000781	0.0113	CcSEcCtD
Nedocromil—HSP90AA1—Signaling by ERBB2—MAPK1—head and neck cancer	0.000778	0.00126	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling by ERBB2—EGFR—head and neck cancer	0.000778	0.00126	CbGpPWpGaD
Nedocromil—Pharyngitis—Docetaxel—head and neck cancer	0.000773	0.0112	CcSEcCtD
Nedocromil—Dizziness—Vinblastine—head and neck cancer	0.000772	0.0112	CcSEcCtD
Nedocromil—HSP90AA1—VEGFA-VEGFR2 Pathway—AKT1—head and neck cancer	0.000772	0.00125	CbGpPWpGaD
Nedocromil—Anaphylactic shock—Fluorouracil—head and neck cancer	0.000767	0.0111	CcSEcCtD
Nedocromil—Asthenia—Hydroxyurea—head and neck cancer	0.000764	0.0111	CcSEcCtD
Nedocromil—CYSLTR1—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—head and neck cancer	0.000754	0.00122	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling by EGFR in Cancer—MAPK3—head and neck cancer	0.000752	0.00122	CbGpPWpGaD
Nedocromil—HSP90AA1—Cell Cycle—TYMS—head and neck cancer	0.000751	0.00122	CbGpPWpGaD
Nedocromil—Visual impairment—Docetaxel—head and neck cancer	0.000751	0.0109	CcSEcCtD
Nedocromil—Vomiting—Vinblastine—head and neck cancer	0.000743	0.0108	CcSEcCtD
Nedocromil—Headache—Vinblastine—head and neck cancer	0.000732	0.0106	CcSEcCtD
Nedocromil—HSP90AA1—Signaling by VEGF—AKT1—head and neck cancer	0.000729	0.00118	CbGpPWpGaD
Nedocromil—Diarrhoea—Hydroxyurea—head and neck cancer	0.000729	0.0106	CcSEcCtD
Nedocromil—CYSLTR1—Signaling Pathways—GRP—head and neck cancer	0.000728	0.00118	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling by EGFR in Cancer—MAPK1—head and neck cancer	0.000715	0.00116	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling by EGFR in Cancer—EGFR—head and neck cancer	0.000715	0.00116	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—STAT6—head and neck cancer	0.000707	0.00114	CbGpPWpGaD
Nedocromil—Dizziness—Hydroxyurea—head and neck cancer	0.000704	0.0102	CcSEcCtD
Nedocromil—CYSLTR1—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—head and neck cancer	0.000697	0.00113	CbGpPWpGaD
Nedocromil—Nausea—Vinblastine—head and neck cancer	0.000694	0.01	CcSEcCtD
Nedocromil—FPR1—GPCR downstream signaling—IL2—head and neck cancer	0.000689	0.00111	CbGpPWpGaD
Nedocromil—Dyspnoea—Fluorouracil—head and neck cancer	0.000683	0.0099	CcSEcCtD
Nedocromil—Vomiting—Hydroxyurea—head and neck cancer	0.000677	0.00981	CcSEcCtD
Nedocromil—HSP90AA1—Signaling by ERBB2—PIK3CA—head and neck cancer	0.000675	0.00109	CbGpPWpGaD
Nedocromil—Dyspepsia—Fluorouracil—head and neck cancer	0.000675	0.00977	CcSEcCtD
Nedocromil—Rash—Hydroxyurea—head and neck cancer	0.000672	0.00972	CcSEcCtD
Nedocromil—Dermatitis—Hydroxyurea—head and neck cancer	0.000671	0.00972	CcSEcCtD
Nedocromil—Headache—Hydroxyurea—head and neck cancer	0.000667	0.00966	CcSEcCtD
Nedocromil—PTGDR—GPCR downstream signaling—IL2—head and neck cancer	0.000665	0.00108	CbGpPWpGaD
Nedocromil—Dysgeusia—Docetaxel—head and neck cancer	0.000664	0.00961	CcSEcCtD
Nedocromil—Gastrointestinal disorder—Fluorouracil—head and neck cancer	0.000662	0.00958	CcSEcCtD
Nedocromil—Pain—Fluorouracil—head and neck cancer	0.000656	0.00949	CcSEcCtD
Nedocromil—HSP90AA1—Metabolism—NAT2—head and neck cancer	0.000646	0.00105	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—KISS1—head and neck cancer	0.000635	0.00103	CbGpPWpGaD
Nedocromil—Nausea—Hydroxyurea—head and neck cancer	0.000633	0.00916	CcSEcCtD
Nedocromil—CYSLTR1—Signaling Pathways—YAP1—head and neck cancer	0.000626	0.00101	CbGpPWpGaD
Nedocromil—FPR1—Signaling by GPCR—IL2—head and neck cancer	0.000625	0.00101	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling by ERBB2—HRAS—head and neck cancer	0.000625	0.00101	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling by EGFR in Cancer—PIK3CA—head and neck cancer	0.000621	0.00101	CbGpPWpGaD
Nedocromil—Urticaria—Fluorouracil—head and neck cancer	0.000609	0.00882	CcSEcCtD
Nedocromil—HSP90AA1—Developmental Biology—NOTCH1—head and neck cancer	0.000609	0.000985	CbGpPWpGaD
Nedocromil—Leukopenia—Docetaxel—head and neck cancer	0.000607	0.00879	CcSEcCtD
Nedocromil—Body temperature increased—Fluorouracil—head and neck cancer	0.000606	0.00878	CcSEcCtD
Nedocromil—PTGDR—Signaling by GPCR—IL2—head and neck cancer	0.000604	0.000978	CbGpPWpGaD
Nedocromil—HSP90AA1—Innate Immune System—BCL2L1—head and neck cancer	0.000599	0.00097	CbGpPWpGaD
Nedocromil—Cough—Docetaxel—head and neck cancer	0.000592	0.00857	CcSEcCtD
Nedocromil—HSP90AA1—Cellular responses to stress—VEGFA—head and neck cancer	0.000588	0.000951	CbGpPWpGaD
Nedocromil—HSP90AA1—Cellular responses to stress—STAT3—head and neck cancer	0.000582	0.000942	CbGpPWpGaD
Nedocromil—Chest pain—Docetaxel—head and neck cancer	0.000577	0.00836	CcSEcCtD
Nedocromil—HSP90AA1—Signaling by EGFR in Cancer—HRAS—head and neck cancer	0.000574	0.00093	CbGpPWpGaD
Nedocromil—HSP90AA1—Metabolism—DPYD—head and neck cancer	0.000566	0.000916	CbGpPWpGaD
Nedocromil—Hypersensitivity—Fluorouracil—head and neck cancer	0.000565	0.00818	CcSEcCtD
Nedocromil—Dry mouth—Docetaxel—head and neck cancer	0.000564	0.00817	CcSEcCtD
Nedocromil—HSP90AA1—Cellular responses to stress—MAPK3—head and neck cancer	0.000556	0.0009	CbGpPWpGaD
Nedocromil—Anaphylactic shock—Docetaxel—head and neck cancer	0.000553	0.00801	CcSEcCtD
Nedocromil—HSP90AA1—Signaling by ERBB2—AKT1—head and neck cancer	0.000551	0.000893	CbGpPWpGaD
Nedocromil—HSP90AA1—Metabolism—YAP1—head and neck cancer	0.000537	0.00087	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—NOTCH1—head and neck cancer	0.000537	0.000869	CbGpPWpGaD
Nedocromil—HSP90AA1—Cellular responses to stress—MAPK1—head and neck cancer	0.000529	0.000856	CbGpPWpGaD
Nedocromil—Diarrhoea—Fluorouracil—head and neck cancer	0.000525	0.0076	CcSEcCtD
Nedocromil—HSP90AA1—Signaling Pathways—GRP—head and neck cancer	0.000523	0.000846	CbGpPWpGaD
Nedocromil—CYSLTR2—GPCR downstream signaling—IL2—head and neck cancer	0.000522	0.000845	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—NOTCH1—head and neck cancer	0.000518	0.000839	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—STAT6—head and neck cancer	0.000507	0.000822	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling by EGFR in Cancer—AKT1—head and neck cancer	0.000507	0.000821	CbGpPWpGaD
Nedocromil—Dizziness—Fluorouracil—head and neck cancer	0.000507	0.00734	CcSEcCtD
Nedocromil—FPR1—Signaling by GPCR—MAPK3—head and neck cancer	0.000503	0.000814	CbGpPWpGaD
Nedocromil—HSP90AA1—Axon guidance—VEGFA—head and neck cancer	0.000499	0.000808	CbGpPWpGaD
Nedocromil—Dyspnoea—Docetaxel—head and neck cancer	0.000493	0.00714	CcSEcCtD
Nedocromil—HSP90AA1—Innate Immune System—CASP8—head and neck cancer	0.00049	0.000793	CbGpPWpGaD
Nedocromil—Vomiting—Fluorouracil—head and neck cancer	0.000487	0.00706	CcSEcCtD
Nedocromil—Dyspepsia—Docetaxel—head and neck cancer	0.000487	0.00705	CcSEcCtD
Nedocromil—PTGDR—Signaling by GPCR—MAPK3—head and neck cancer	0.000486	0.000786	CbGpPWpGaD
Nedocromil—Rash—Fluorouracil—head and neck cancer	0.000483	0.007	CcSEcCtD
Nedocromil—Dermatitis—Fluorouracil—head and neck cancer	0.000483	0.00699	CcSEcCtD
Nedocromil—Headache—Fluorouracil—head and neck cancer	0.00048	0.00695	CcSEcCtD
Nedocromil—FPR1—Signaling by GPCR—MAPK1—head and neck cancer	0.000478	0.000775	CbGpPWpGaD
Nedocromil—FPR1—Signaling by GPCR—EGFR—head and neck cancer	0.000478	0.000774	CbGpPWpGaD
Nedocromil—Gastrointestinal disorder—Docetaxel—head and neck cancer	0.000478	0.00692	CcSEcCtD
Nedocromil—Fatigue—Docetaxel—head and neck cancer	0.000477	0.00691	CcSEcCtD
Nedocromil—CYSLTR2—Signaling by GPCR—IL2—head and neck cancer	0.000474	0.000767	CbGpPWpGaD
Nedocromil—Pain—Docetaxel—head and neck cancer	0.000473	0.00685	CcSEcCtD
Nedocromil—HSP90AA1—Axon guidance—MAPK3—head and neck cancer	0.000472	0.000764	CbGpPWpGaD
Nedocromil—PTGDR—Signaling by GPCR—MAPK1—head and neck cancer	0.000462	0.000748	CbGpPWpGaD
Nedocromil—PTGDR—Signaling by GPCR—EGFR—head and neck cancer	0.000462	0.000748	CbGpPWpGaD
Nedocromil—FPR1—GPCR downstream signaling—PIK3CA—head and neck cancer	0.000457	0.00074	CbGpPWpGaD
Nedocromil—Nausea—Fluorouracil—head and neck cancer	0.000455	0.00659	CcSEcCtD
Nedocromil—Gastrointestinal pain—Docetaxel—head and neck cancer	0.000452	0.00655	CcSEcCtD
Nedocromil—HSP90AA1—Signaling Pathways—YAP1—head and neck cancer	0.000449	0.000727	CbGpPWpGaD
Nedocromil—HSP90AA1—Axon guidance—MAPK1—head and neck cancer	0.000449	0.000727	CbGpPWpGaD
Nedocromil—HSP90AA1—Axon guidance—EGFR—head and neck cancer	0.000449	0.000727	CbGpPWpGaD
Nedocromil—HSP90AA1—Cellular responses to stress—TP53—head and neck cancer	0.000444	0.000719	CbGpPWpGaD
Nedocromil—PTGDR—GPCR downstream signaling—PIK3CA—head and neck cancer	0.000441	0.000715	CbGpPWpGaD
Nedocromil—Body temperature increased—Docetaxel—head and neck cancer	0.000437	0.00633	CcSEcCtD
Nedocromil—Abdominal pain—Docetaxel—head and neck cancer	0.000437	0.00633	CcSEcCtD
Nedocromil—HSP90AA1—Cell Cycle, Mitotic—CCND1—head and neck cancer	0.000423	0.000684	CbGpPWpGaD
Nedocromil—HSP90AA1—Innate Immune System—BCL2—head and neck cancer	0.00042	0.00068	CbGpPWpGaD
Nedocromil—FPR1—Signaling by GPCR—PIK3CA—head and neck cancer	0.000415	0.000672	CbGpPWpGaD
Nedocromil—Hypersensitivity—Docetaxel—head and neck cancer	0.000408	0.0059	CcSEcCtD
Nedocromil—CYSLTR2—Signaling Pathways—NOTCH1—head and neck cancer	0.000407	0.000659	CbGpPWpGaD
Nedocromil—PTGDR—Signaling by GPCR—PIK3CA—head and neck cancer	0.000401	0.000649	CbGpPWpGaD
Nedocromil—Asthenia—Docetaxel—head and neck cancer	0.000397	0.00575	CcSEcCtD
Nedocromil—FPR1—Signaling by GPCR—HRAS—head and neck cancer	0.000384	0.000622	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling by GPCR—MAPK3—head and neck cancer	0.000381	0.000617	CbGpPWpGaD
Nedocromil—Diarrhoea—Docetaxel—head and neck cancer	0.000379	0.00548	CcSEcCtD
Nedocromil—HSP90AA1—Cell Cycle—CCND1—head and neck cancer	0.000378	0.000612	CbGpPWpGaD
Nedocromil—FPR1—GPCR downstream signaling—AKT1—head and neck cancer	0.000373	0.000605	CbGpPWpGaD
Nedocromil—PTGDR—Signaling by GPCR—HRAS—head and neck cancer	0.000371	0.000601	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—IL2—head and neck cancer	0.000369	0.000598	CbGpPWpGaD
Nedocromil—Dizziness—Docetaxel—head and neck cancer	0.000366	0.0053	CcSEcCtD
Nedocromil—CYSLTR2—Signaling by GPCR—MAPK1—head and neck cancer	0.000363	0.000587	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling by GPCR—EGFR—head and neck cancer	0.000362	0.000587	CbGpPWpGaD
Nedocromil—CYSLTR1—GPCR downstream signaling—IL2—head and neck cancer	0.000362	0.000586	CbGpPWpGaD
Nedocromil—PTGDR—GPCR downstream signaling—AKT1—head and neck cancer	0.000361	0.000584	CbGpPWpGaD
Nedocromil—HSP90AA1—Axon guidance—HRAS—head and neck cancer	0.00036	0.000584	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—CCND1—head and neck cancer	0.00036	0.000583	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—IL2—head and neck cancer	0.000357	0.000578	CbGpPWpGaD
Nedocromil—HSP90AA1—Developmental Biology—VEGFA—head and neck cancer	0.000356	0.000576	CbGpPWpGaD
Nedocromil—HSP90AA1—Developmental Biology—STAT3—head and neck cancer	0.000352	0.000571	CbGpPWpGaD
Nedocromil—Vomiting—Docetaxel—head and neck cancer	0.000352	0.00509	CcSEcCtD
Nedocromil—Rash—Docetaxel—head and neck cancer	0.000349	0.00505	CcSEcCtD
Nedocromil—HSP90AA1—Immune System—BCL2L1—head and neck cancer	0.000349	0.000565	CbGpPWpGaD
Nedocromil—HSP90AA1—Cell Cycle, Mitotic—MAPK3—head and neck cancer	0.000349	0.000564	CbGpPWpGaD
Nedocromil—Dermatitis—Docetaxel—head and neck cancer	0.000349	0.00505	CcSEcCtD
Nedocromil—HSP90AA1—Innate Immune System—PTEN—head and neck cancer	0.000348	0.000564	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—CCND1—head and neck cancer	0.000348	0.000563	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—PTEN—head and neck cancer	0.000348	0.000563	CbGpPWpGaD
Nedocromil—Headache—Docetaxel—head and neck cancer	0.000347	0.00502	CcSEcCtD
Nedocromil—CYSLTR2—GPCR downstream signaling—PIK3CA—head and neck cancer	0.000346	0.000561	CbGpPWpGaD
Nedocromil—FPR1—Signaling by GPCR—AKT1—head and neck cancer	0.000339	0.000549	CbGpPWpGaD
Nedocromil—HSP90AA1—Developmental Biology—MAPK3—head and neck cancer	0.000337	0.000545	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—PTEN—head and neck cancer	0.000336	0.000544	CbGpPWpGaD
Nedocromil—HSP90AA1—Cell Cycle, Mitotic—MAPK1—head and neck cancer	0.000332	0.000537	CbGpPWpGaD
Nedocromil—Nausea—Docetaxel—head and neck cancer	0.000329	0.00476	CcSEcCtD
Nedocromil—CYSLTR1—Signaling by GPCR—IL2—head and neck cancer	0.000329	0.000532	CbGpPWpGaD
Nedocromil—PTGDR—Signaling by GPCR—AKT1—head and neck cancer	0.000328	0.00053	CbGpPWpGaD
Nedocromil—HSP90AA1—Metabolism—TYMS—head and neck cancer	0.000323	0.000522	CbGpPWpGaD
Nedocromil—HSP90AA1—Developmental Biology—MAPK1—head and neck cancer	0.00032	0.000519	CbGpPWpGaD
Nedocromil—HSP90AA1—Developmental Biology—EGFR—head and neck cancer	0.00032	0.000519	CbGpPWpGaD
Nedocromil—HSP90AA1—Metabolism—GSTM1—head and neck cancer	0.000319	0.000516	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling by GPCR—PIK3CA—head and neck cancer	0.000315	0.000509	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—VEGFA—head and neck cancer	0.000314	0.000508	CbGpPWpGaD
Nedocromil—HSP90AA1—Cell Cycle—MAPK3—head and neck cancer	0.000312	0.000505	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—STAT3—head and neck cancer	0.000311	0.000503	CbGpPWpGaD
Nedocromil—HSP90AA1—Metabolism—GPX1—head and neck cancer	0.000305	0.000494	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—VEGFA—head and neck cancer	0.000303	0.000491	CbGpPWpGaD
Nedocromil—HSP90AA1—Metabolism—CYP1A1—head and neck cancer	0.000302	0.000489	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—STAT3—head and neck cancer	0.0003	0.000486	CbGpPWpGaD
Nedocromil—HSP90AA1—Innate Immune System—MAPK3—head and neck cancer	0.000297	0.000481	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—MAPK3—head and neck cancer	0.000297	0.000481	CbGpPWpGaD
Nedocromil—HSP90AA1—Cell Cycle—MAPK1—head and neck cancer	0.000297	0.00048	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling by GPCR—HRAS—head and neck cancer	0.000291	0.000471	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—NOTCH1—head and neck cancer	0.000289	0.000468	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—MAPK3—head and neck cancer	0.000287	0.000464	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—CASP8—head and neck cancer	0.000285	0.000462	CbGpPWpGaD
Nedocromil—CYSLTR2—GPCR downstream signaling—AKT1—head and neck cancer	0.000283	0.000458	CbGpPWpGaD
Nedocromil—HSP90AA1—Innate Immune System—MAPK1—head and neck cancer	0.000283	0.000458	CbGpPWpGaD
Nedocromil—HSP90AA1—Innate Immune System—EGFR—head and neck cancer	0.000283	0.000458	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—MAPK1—head and neck cancer	0.000283	0.000458	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—EGFR—head and neck cancer	0.000283	0.000457	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—NOTCH1—head and neck cancer	0.000282	0.000457	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—CDH1—head and neck cancer	0.000282	0.000456	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—IL2—head and neck cancer	0.00028	0.000453	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—MAPK1—head and neck cancer	0.000273	0.000442	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—CCND1—head and neck cancer	0.000273	0.000442	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—EGFR—head and neck cancer	0.000273	0.000442	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling by GPCR—MAPK3—head and neck cancer	0.000264	0.000428	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—PTEN—head and neck cancer	0.000263	0.000427	CbGpPWpGaD
Nedocromil—HSP90AA1—Developmental Biology—HRAS—head and neck cancer	0.000257	0.000416	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling by GPCR—AKT1—head and neck cancer	0.000257	0.000416	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling by GPCR—MAPK1—head and neck cancer	0.000251	0.000407	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling by GPCR—EGFR—head and neck cancer	0.000251	0.000407	CbGpPWpGaD
Nedocromil—HSP90AA1—Cell Cycle—TP53—head and neck cancer	0.000249	0.000403	CbGpPWpGaD
Nedocromil—HSP90AA1—Innate Immune System—PIK3CA—head and neck cancer	0.000246	0.000398	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—PIK3CA—head and neck cancer	0.000245	0.000397	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—BCL2—head and neck cancer	0.000245	0.000396	CbGpPWpGaD
Nedocromil—CYSLTR1—GPCR downstream signaling—PIK3CA—head and neck cancer	0.00024	0.000389	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—VEGFA—head and neck cancer	0.000238	0.000385	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—TP53—head and neck cancer	0.000237	0.000384	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—PIK3CA—head and neck cancer	0.000237	0.000383	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—STAT3—head and neck cancer	0.000236	0.000381	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—TP53—head and neck cancer	0.000229	0.000371	CbGpPWpGaD
Nedocromil—HSP90AA1—Innate Immune System—HRAS—head and neck cancer	0.000227	0.000368	CbGpPWpGaD
Nedocromil—HSP90AA1—Developmental Biology—AKT1—head and neck cancer	0.000227	0.000368	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—HRAS—head and neck cancer	0.000227	0.000367	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—MAPK3—head and neck cancer	0.000225	0.000364	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—HRAS—head and neck cancer	0.000219	0.000355	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling by GPCR—PIK3CA—head and neck cancer	0.000218	0.000353	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—IL2—head and neck cancer	0.000215	0.000349	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—PTGS2—head and neck cancer	0.000215	0.000347	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—MAPK1—head and neck cancer	0.000214	0.000347	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—EGFR—head and neck cancer	0.000214	0.000347	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—PTEN—head and neck cancer	0.000203	0.000328	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—NOTCH1—head and neck cancer	0.000202	0.000328	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling by GPCR—HRAS—head and neck cancer	0.000202	0.000327	CbGpPWpGaD
Nedocromil—HSP90AA1—Innate Immune System—AKT1—head and neck cancer	0.000201	0.000325	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—AKT1—head and neck cancer	0.0002	0.000324	CbGpPWpGaD
Nedocromil—CYSLTR1—GPCR downstream signaling—AKT1—head and neck cancer	0.000196	0.000318	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—IL2—head and neck cancer	0.000194	0.000314	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—AKT1—head and neck cancer	0.000193	0.000313	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—CCND1—head and neck cancer	0.000189	0.000306	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—PTEN—head and neck cancer	0.000187	0.000303	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—PIK3CA—head and neck cancer	0.000186	0.000301	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—PTEN—head and neck cancer	0.000183	0.000296	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—STAT3—head and neck cancer	0.000181	0.000294	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—TP53—head and neck cancer	0.00018	0.000291	CbGpPWpGaD
Nedocromil—HSP90AA1—Metabolism—PTGS2—head and neck cancer	0.00018	0.000291	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling by GPCR—AKT1—head and neck cancer	0.000178	0.000288	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—MAPK3—head and neck cancer	0.000173	0.00028	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—HRAS—head and neck cancer	0.000172	0.000278	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—STAT3—head and neck cancer	0.000167	0.000271	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—VEGFA—head and neck cancer	0.000165	0.000267	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—MAPK1—head and neck cancer	0.000165	0.000267	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—EGFR—head and neck cancer	0.000165	0.000267	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—STAT3—head and neck cancer	0.000163	0.000264	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—MAPK3—head and neck cancer	0.00016	0.000259	CbGpPWpGaD
Nedocromil—HSP90AA1—Metabolism—PTEN—head and neck cancer	0.000157	0.000254	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—MAPK3—head and neck cancer	0.000156	0.000253	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—MAPK1—head and neck cancer	0.000152	0.000246	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—EGFR—head and neck cancer	0.000152	0.000246	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—AKT1—head and neck cancer	0.000152	0.000246	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—MAPK1—head and neck cancer	0.000148	0.00024	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—EGFR—head and neck cancer	0.000148	0.00024	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—PIK3CA—head and neck cancer	0.000143	0.000232	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—IL2—head and neck cancer	0.000139	0.000226	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—CCND1—head and neck cancer	0.000136	0.00022	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—HRAS—head and neck cancer	0.000132	0.000214	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—PIK3CA—head and neck cancer	0.000132	0.000214	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—PTEN—head and neck cancer	0.000131	0.000212	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—PIK3CA—head and neck cancer	0.000129	0.000209	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—TP53—head and neck cancer	0.000125	0.000202	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—HRAS—head and neck cancer	0.000122	0.000198	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—HRAS—head and neck cancer	0.000119	0.000193	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—VEGFA—head and neck cancer	0.000118	0.000192	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—STAT3—head and neck cancer	0.000117	0.00019	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—AKT1—head and neck cancer	0.000117	0.000189	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—MAPK3—head and neck cancer	0.000112	0.000181	CbGpPWpGaD
Nedocromil—HSP90AA1—Metabolism—PIK3CA—head and neck cancer	0.000111	0.000179	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—AKT1—head and neck cancer	0.000108	0.000175	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—MAPK1—head and neck cancer	0.000107	0.000173	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—EGFR—head and neck cancer	0.000107	0.000172	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—AKT1—head and neck cancer	0.000105	0.00017	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—PIK3CA—head and neck cancer	9.25e-05	0.00015	CbGpPWpGaD
Nedocromil—HSP90AA1—Metabolism—AKT1—head and neck cancer	9.03e-05	0.000146	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—TP53—head and neck cancer	8.95e-05	0.000145	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—HRAS—head and neck cancer	8.55e-05	0.000139	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—AKT1—head and neck cancer	7.55e-05	0.000122	CbGpPWpGaD
